Molecular and genetic aspects of triple negative breast cancer and therapeutic implications;Aspects moléculaires du cancer du sein triple négatif et les implications thérapeutiques

Revue Medicale de Liege

Volumn 66, Issue 5-6, 2011, Pages 393-396

  Collignon, J ^a   Struman, I ^b   Tabruyn, S ^c   Josse, C ^d   Boukerroucha, M ^a   Jerusalem, G ^a   Bours, V ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Chercheur Qualifié FNRS ^*  (Belgium)

^c Chargé de Recherche FNRS   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

MicroRNA; Molecular subtype; Targeted therapy; Triple negative breast cancer

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; MICRORNA; PROGESTERONE;

CANCER GENETICS; CANCER THERAPY; MOLECULAR BIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TRIPLE NEGATIVE BREAST CANCER;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; PROTEIN KINASE INHIBITORS; UBIQUITIN-PROTEIN LIGASES;

EID: 80051677636     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Foulkes WD, Smith IE, Reis-Filho JS. - Triple-negative breast cancer. N Engl J Med, 2010, 363, 1938-1948.
2. Reis-Filho JS, Tutt AN. - Triple negative tumours: a critical review. Histopathology, 2008, 52, 108-118. (Pubitemid 350265179)
3. Carey LA. - Directed therapy of subtypes of triple-negative breast cancer. Oncologist, 2010, 15, 49-56.
4. Perou CM. - Molecular stratification of triple-negative breast cancers. Oncologist, 2010, 15, 39-48.
5. Prat A, Perou CM. - Deconstructing the molecular portraits of breast cancer. Mol Oncol, 2011, 5, 5-23.
6. Irvin WJ, Carey LA. - What is triple-negative breast cancer? Eur J Cancer, 2008, 44, 2799-2805.
7. Rakha EA, Reis-Filho JS, Ellis IO. - Basal-like breast cancer: a critical review. J Clin Oncol, 2008, 26, 2568-2581.
8. Ashworth A. - A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol, 2008, 26, 3785-3790.
9. Esteller M. - Epigenetics in cancer. N Engl J Med, 2008, 358, 1148-1159.
10. Tost J. - DNA methylation : an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol, 2009, 507, 3-20.
11. Underhill C, Toulmonde M, Bonnefoi H. - A review of PARP inhibitors: from bench to bedside. Ann Oncol, 2011, 22, 268-279.
12. Slack FJ, Weidhaas JB. - MicroRNA in cancer prognosis. N Engl J Med, 2008, 359, 2720-2722.
13. Mitchell PS, Parkin RK, Kroh EM, et al. - Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 2008, 105, 10513-10518.
14. O'Day E, Lal A. - MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res, 2010, 12, 201. Epub 2010, Mar 19.
15. Radojicic J, Zaravinos A, Vrekoussis T, et al. - MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle, 2011, 10, 507-517.
16. Podo F, Buydens LM, Degani H, et al. - Triple-negative breast cancer : present challenges and new perspectives. Mol Oncol, 2010, 4, 209-229.
17. Silver DP, Richardson AL, Eklund AC, et al. - Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol, 2010, 28, 1145-1153.
18. Kornblith AB, Lan L, Archer L, et al. - Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy : a companion study to cancer and leukemia group B 49907. J Clin Oncol, 2011, 29, 1022-1028.
19. O'Shaughnessy J, Osborne C, Pippen JE, et al. - Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med, 2011, 364, 205-214.
20. Fong PC, Boss DS, Yap TA, et al. - Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med, 2009, 361, 123-134.